RT @christeeny513: Adjuvant #endocrinetherapy for #breastcancer patients still unclear. SOFT trial showed no benefit w/ ovarian function su…
924 followers
3,367 followers
Adjuvant #endocrinetherapy for #breastcancer patients still unclear. SOFT trial showed no benefit w/ ovarian function suppression (OFS) + Tamoxifen, but this #korean trial may have different results. What are implications for #MBC patients? #ASCO18 #BCSM h
1,051 followers
The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive… https://t.co/PieutEv9rR #breastcancer
1,051 followers
The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive… https://t.co/Ui4j2WOdbS #breastcancer